Interestingly, ATP2B4 (PMCA4B) is also a predicted target of miR-96-5p, previously found to be upregulated in plasma and osteoblast samples from AIS patients in Chinese and French-Canadian populations [30]. The gene discussed is ATP2B4; the disease is androgen insensitivity syndrome.